The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $900,000 in first-year total cost, median $225,000.
Most frequent study sections
- Special Emphasis Panel[ZAR1 YL (M2)]4
Most frequent institutions
- CELDARA MEDICAL, LLC1
- CFD RESEARCH CORPORATION1
- CYTEX THERAPEUTICS INC.1
- RAPUNZEL BIOSCIENCE, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | A 3D osteoarthritis model targeting patient populations with high risk genetic polymorphisms1R43AR072166-01 | WILLARD, VINCENT P | CYTEX THERAPEUTICS INC., NC | $225,000 | ZAR1 |
| 2017 | Engineering Hair Follicles in Vascularized 3D Skin Models1R43AR072168-01 | CHRISTIANO, ANGELA MSEE, DONNA | RAPUNZEL BIOSCIENCE, INC., NY | $225,000 | ZAR1 |
| 2017 | Multi-Scale In Vitro 3D Tissue Model of Vascularized Bone-Cartilage Interactions1R43AR072169-01 | PRABHAKARPANDIAN, BALABHASKAR | CFD RESEARCH CORPORATION, AL | $225,000 | ZAR1 |
| 2017 | Complex 3-Dimensional in Vitro Human Skin Tissue Models for Scleroderma1R43AR072170-01 | FANGER, MICHAEL W | CELDARA MEDICAL, LLC, NH | $225,000 | ZAR1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.